[1]
Chandra, S.; Alam, M.T.; Dey, J.Pulikkaparambil; Sasidharan, B.C.; Ray, U.; Srivastava, A.K.; Gandhi, S.; Tripathi, P.P. Healthy gut, healthy brain: the gut microbiome in neurodegenerative disorders. Curr. Top. Med. Chem., 2020, 20(13), 1142-1153.
[2]
Datta, A.; Sarmah, D.; Kalia, K.; Borah, A.; Wang, X.; Dave, K.R.; Yavagal, D.R.; Bhattacharya, P. Advances in studies on stroke-induced secondary neurodegeneration (SND) and its treatment. Curr. Top. Med. Chem., 2020, 20(13), 1154-1168.
[3]
Maan, G.; Sikdar, B.; Kumar, A.; Shukla, R.; Mishra, A. Role of flavonoids in neurodegenerative diseases: limitations and future perspectives. Curr. Top. Med. Chem., 2020, 20(13), 1169-1194.
Current Topics in Medicinal Chemistry
Title:Advances in Studies on Neurodegenerative Diseases and their Treatments
Volume: 20 Issue: 13
Author(s): Satya P. Gupta
Affiliation:
Export Options
About this article
Cite this article as:
Gupta P. Satya , Advances in Studies on Neurodegenerative Diseases and their Treatments, Current Topics in Medicinal Chemistry 2020; 20 (13) . https://dx.doi.org/10.2174/156802662013200519075027
DOI https://dx.doi.org/10.2174/156802662013200519075027 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
9
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
5-Adenosine Monophosphate-Activated Protein Kinase and the Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Curcumin Activates the Nrf2 Pathway and Induces Cellular Protection Against Oxidative Injury
Current Molecular Medicine Inflammation in Neurodegenerative Disorders: Friend or Foe?
Current Aging Science PDE7-Selective and Dual Inhibitors: Advances in Chemical and Biological Research
Current Medicinal Chemistry Therapeutic Targets for the Management of Peripheral Nerve Injury- Induced Neuropathic Pain
CNS & Neurological Disorders - Drug Targets Neuronal Ceroid Lipofuscinosis: The Increasing Spectrum of an Old Disease
Current Molecular Medicine Clinical Aspects of Melatonin Intervention in Alzheimers Disease Progression
Current Neuropharmacology Cubosomes: Innovative Nanostructures for Drug Delivery
Current Drug Delivery Tau Oligomers as Potential Targets for Immunotherapy for Alzheimers Disease and Tauopathies
Current Alzheimer Research Subject Index To Volume 12
Current Pharmaceutical Design Neurotrophic Factors in Combination: A Possible new Therapeutic Strategy to Influence Pathophysiology of Spinal Cord Injury and Repair Mechanisms
Current Pharmaceutical Design Magnetic Materials for the Selective Analysis of Peptide and Protein Biomarkers
Current Medicinal Chemistry Molecular Hydrogen Application in Stroke: Bench to Bedside
Current Pharmaceutical Design Citicoline and Retinal Ganglion Cells: Effects on Morphology and Function
Current Neuropharmacology Multifunctional Nanoparticles, Nanocages and Degradable Polymers as a Potential Novel Generation of Non-Invasive Molecular and Cellular Imaging Systems
Recent Patents on Nanotechnology REM sleep and its Loss-Associated Epigenetic Regulation with Reference to Noradrenaline in Particular
Current Neuropharmacology Applications of Chemical Shift Imaging for AD
Current Medical Imaging Modulation of Endoplasmic Reticulum Stress: An Opportunity to Prevent Neurodegeneration?
CNS & Neurological Disorders - Drug Targets Tacrine Derivatives and Alzheimers Disease
Current Medicinal Chemistry Brain Functional Effects of Psychopharmacological Treatments in Schizophrenia: A Network-based Functional Perspective Beyond Neurotransmitter Systems
Current Neuropharmacology